• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO EUPHORA RX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO EUPHORA RX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Catalog Number EUP3015X
Medical Device Problem Code Burst Container or Vessel (1074)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 06/10/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
During a procedure an attempt was made to use a euphora rx ptca balloon catheter, an nc euphora rx ptca balloon catheter, and a resolute onyx rx coronary drug eluting stent to treat a non tortuous, severely calcified lesion in ostium of the left main (lm) coronary artery.The devices were inspected with no issues noted.Negative prep was performed with no issues noted.The lesion was pre dilated using a cutting balloon.The devices did not pass through a previously deployed stent.Resistance was not encountered during delivery of the nc euphora and the resolute onyx devices.Excessive force was not used during delivery of all three devices.It was reported that all three devices burst when inflated to 12 atm.The resolute onyx burst during stent deployment.One inflation had been applied to the resolute onyx prior to the burst.No patient injury reported.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
The account stated no serious injury occurred.The account stated all three medtronic products burst during the intervention.If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
The resolute onyx stent needed to be post-dilated after the burst occurred.The same non-medtronic inflation device was used with all three medtronic devices.The devices were not moved or repositioned prior to the bursts.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUPHORA RX
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX  22570
MDR Report Key8690528
Report Number9612164-2019-02284
Device Sequence Number11266998
Product Code LOX
UDI-Device Identifier00643169560154
UDI-Public00643169560154
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K143480
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 10/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/21/2021
Device Catalogue NumberEUP3015X
Device Lot Number217371291
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 06/11/2019
Supplement Date Received by Manufacturer06/24/2019
08/30/2019
10/26/2019
Initial Report FDA Received Date06/12/2019
Supplement Report FDA Received Date07/22/2019
09/25/2019
10/29/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age74 YR
Patient Weight55
-
-